These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 25759766)

  • 1. Treatment of early stage non-small cell lung cancer: surgery or stereotactic ablative radiotherapy?
    Uzel EK; Abacıoğlu U
    Balkan Med J; 2015 Jan; 32(1):8-16. PubMed ID: 25759766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgery or stereotactic ablative radiation therapy: how will be treated operable patients with early stage not small cell lung cancer in the next future?
    Bertolaccini L; Terzi A; Ricchetti F; Alongi F
    Ann Transl Med; 2015 Feb; 3(2):25. PubMed ID: 25738145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereotactic ablative radiotherapy for operable stage I non-small-cell lung cancer (revised STARS): long-term results of a single-arm, prospective trial with prespecified comparison to surgery.
    Chang JY; Mehran RJ; Feng L; Verma V; Liao Z; Welsh JW; Lin SH; O'Reilly MS; Jeter MD; Balter PA; McRae SE; Berry D; Heymach JV; Roth JA;
    Lancet Oncol; 2021 Oct; 22(10):1448-1457. PubMed ID: 34529930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minimally invasive lobectomy versus stereotactic ablative radiotherapy for stage I non-small cell lung cancer.
    de Ruiter JC; van Diessen JNA; Smit EF; van der Noort V; Damhuis RAM; Hartemink KJ;
    Eur J Cardiothorac Surg; 2022 Aug; 62(3):. PubMed ID: 35348664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved survival with stereotactic ablative radiotherapy (SABR) over lobectomy for early stage non-small cell lung cancer (NSCLC): addressing the fallout of disruptive randomized data.
    Rusthoven CG; Kavanagh BD; Karam SD
    Ann Transl Med; 2015 Jul; 3(11):149. PubMed ID: 26244136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Additional data in the debate on stage I non-small cell lung cancer: surgery versus stereotactic ablative radiotherapy.
    Simone CB; Dorsey JF
    Ann Transl Med; 2015 Aug; 3(13):172. PubMed ID: 26366389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stage I-II non-small-cell lung cancer treated using either stereotactic ablative radiotherapy (SABR) or lobectomy by video-assisted thoracoscopic surgery (VATS): outcomes of a propensity score-matched analysis.
    Verstegen NE; Oosterhuis JW; Palma DA; Rodrigues G; Lagerwaard FJ; van der Elst A; Mollema R; van Tets WF; Warner A; Joosten JJ; Amir MI; Haasbeek CJ; Smit EF; Slotman BJ; Senan S
    Ann Oncol; 2013 Jun; 24(6):1543-8. PubMed ID: 23425947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Video-assisted thoracoscopic lobectomy is associated with greater recurrence-free survival than stereotactic body radiotherapy for clinical stage I lung cancer.
    Cornwell LD; Echeverria AE; Samuelian J; Mayor J; Casal RF; Bakaeen FG; Omer S; Preventza O; Mai W; Chen G; Simpson KH; Moghanaki D; Zhu AW
    J Thorac Cardiovasc Surg; 2018 Jan; 155(1):395-402. PubMed ID: 28888379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient reported outcomes following video assisted thoracoscopic (VATS) resection or stereotactic ablative body radiotherapy (SABR) for treatment of non-small cell lung cancer: protocol for an observational pilot study (LiLAC).
    Pompili C; Franks KN; Brunelli A; Hussain YS; Holch P; Callister ME; Robson JM; Papagiannopoulos K; Velikova G
    J Thorac Dis; 2017 Aug; 9(8):2703-2713. PubMed ID: 28932579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of stage I and II non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.
    Howington JA; Blum MG; Chang AC; Balekian AA; Murthy SC
    Chest; 2013 May; 143(5 Suppl):e278S-e313S. PubMed ID: 23649443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgery versus stereotactic ablative radiotherapy (SABR) for early-stage non-small cell lung cancer: less is not more.
    White A; Swanson SJ
    J Thorac Dis; 2016 Apr; 8(Suppl 4):S399-405. PubMed ID: 27195137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials.
    Chang JY; Senan S; Paul MA; Mehran RJ; Louie AV; Balter P; Groen HJ; McRae SE; Widder J; Feng L; van den Borne BE; Munsell MF; Hurkmans C; Berry DA; van Werkhoven E; Kresl JJ; Dingemans AM; Dawood O; Haasbeek CJ; Carpenter LS; De Jaeger K; Komaki R; Slotman BJ; Smit EF; Roth JA
    Lancet Oncol; 2015 Jun; 16(6):630-7. PubMed ID: 25981812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereotactic radiotherapy for early stage non-small cell lung cancer: current standards and ongoing research.
    Vlaskou Badra E; Baumgartl M; Fabiano S; Jongen A; Guckenberger M
    Transl Lung Cancer Res; 2021 Apr; 10(4):1930-1949. PubMed ID: 34012804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endoscopic nodal staging in oligometastatic non-small cell lung cancer (NSCLC) being treated with stereotactic ablative radiotherapy (ENDO-SABR).
    Dhaliwal I; Kassirian S; Mitchell MA; Qiabi M; Warner A; Louie AV; Wong HH; McDonald CM; Rajchgot J; Palma DA
    BMC Cancer; 2022 Apr; 22(1):468. PubMed ID: 35484614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alternatives to surgery for early stage non-small cell lung cancer-ready for prime time?
    Das M; Abdelmaksoud MH; Loo BW; Kothary N
    Curr Treat Options Oncol; 2010 Jun; 11(1-2):24-35. PubMed ID: 20577833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is radiofrequency ablation more effective than stereotactic ablative radiotherapy in patients with early stage medically inoperable non-small cell lung cancer?
    Bilal H; Mahmood S; Rajashanker B; Shah R
    Interact Cardiovasc Thorac Surg; 2012 Aug; 15(2):258-65. PubMed ID: 22581864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness analysis of stereotactic body radiotherapy and surgery for medically operable early stage non small cell lung cancer.
    Paix A; Noel G; Falcoz PE; Levy P
    Radiother Oncol; 2018 Sep; 128(3):534-540. PubMed ID: 29706462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereotactic Ablative Radiotherapy as an Alternative to Lobectomy in Patients With Medically Operable Stage I NSCLC: A Retrospective, Multicenter Analysis.
    Scotti V; Bruni A; Francolini G; Perna M; Vasilyeva P; Loi M; Simontacchi G; Viggiano D; Lanfranchi B; Gonfiotti A; Topulli J; Olmetto E; Maragna V; Ferrari K; Bonti V; Comin C; Balduzzi S; D'Amico R; Lohr F; Voltolini L; Livi L
    Clin Lung Cancer; 2019 Jan; 20(1):e53-e61. PubMed ID: 30348595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereotactic body radiation therapy (SBRT) for early stage non-small cell lung cancer (NSCLC): contemporary insights and advances.
    Sebastian NT; Xu-Welliver M; Williams TM
    J Thorac Dis; 2018 Aug; 10(Suppl 21):S2451-S2464. PubMed ID: 30206491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An optimal dose-fractionation for stereotactic body radiotherapy in peripherally, centrally and ultracentrally located early-stage non-small lung cancer.
    Zarębska I; Harat M
    Thorac Cancer; 2023 Oct; 14(28):2813-2820. PubMed ID: 37691151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.